www.fdanews.com/articles/202741-chordate-medical-earns-additional-ce-marking-for-neuromodulation-treatment
Chordate Medical Earns Additional CE Marking for Neuromodulation Treatment
May 13, 2021
Chordate Medical has obtained an expanded CE mark for its Kinetic Oscillation Stimulation (KOS) device that clears the neuromodulator for treating chronic migraines.
The preventive treatment uses vibrations given over several sessions to stimulate the nerves in the mucous membranes of the nose to treat chronic rhinitis and migraines.
The device was previously CE marked for treating chronic nasal congestion and rhinitis. It may now be used in Europe for treating chronic migraines.